Beijing Succeeder Technology Inc (688338) - Total Assets
Based on the latest financial reports, Beijing Succeeder Technology Inc (688338) holds total assets worth CN¥1.78 Billion CNY (≈ $260.19 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Beijing Succeeder Technology Inc (688338) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Beijing Succeeder Technology Inc - Total Assets Trend (2016–2025)
This chart illustrates how Beijing Succeeder Technology Inc's total assets have evolved over time, based on quarterly financial data. See Beijing Succeeder Technology Inc (688338) net assets for net asset value and shareholders' equity analysis.
Beijing Succeeder Technology Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Beijing Succeeder Technology Inc's total assets of CN¥1.78 Billion consist of 79.6% current assets and 20.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 44.2% |
| Accounts Receivable | CN¥53.97 Million | 3.1% |
| Inventory | CN¥42.47 Million | 2.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥21.03 Million | 1.2% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Beijing Succeeder Technology Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Beijing Succeeder Technology Inc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Beijing Succeeder Technology Inc's current assets represent 79.6% of total assets in 2025, an increase from 73.9% in 2016.
- Cash Position: Cash and equivalents constituted 44.2% of total assets in 2025, down from 59.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 3.1% of total assets.
Beijing Succeeder Technology Inc Competitors by Total Assets
Key competitors of Beijing Succeeder Technology Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM
|
USA | $101.85 Million |
|
Allmed Solutions Ltd
TA:ALMD
|
Israel | ILA31.54 Million |
|
Universal Biosensors Inc
AU:UBI
|
Australia | AU$14.94 Million |
Beijing Succeeder Technology Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 20.80 | 15.66 | 16.75 |
| Quick Ratio | 20.17 | 15.18 | 16.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.35 Billion | CN¥1.30 Billion | CN¥1.29 Billion |
Beijing Succeeder Technology Inc - Advanced Valuation Insights
This section examines the relationship between Beijing Succeeder Technology Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.77 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | 1.0% |
| Total Assets | CN¥1.77 Billion |
| Market Capitalization | $418.59 Million USD |
Valuation Analysis
Below Book Valuation: The market values Beijing Succeeder Technology Inc's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Beijing Succeeder Technology Inc's assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Beijing Succeeder Technology Inc (2016–2025)
The table below shows the annual total assets of Beijing Succeeder Technology Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.77 Billion ≈ $258.35 Million |
+0.97% |
| 2024-12-31 | CN¥1.75 Billion ≈ $255.88 Million |
+2.49% |
| 2023-12-31 | CN¥1.71 Billion ≈ $249.68 Million |
+5.85% |
| 2022-12-31 | CN¥1.61 Billion ≈ $235.89 Million |
+8.64% |
| 2021-12-31 | CN¥1.48 Billion ≈ $217.12 Million |
+5.87% |
| 2020-12-31 | CN¥1.40 Billion ≈ $205.08 Million |
+228.45% |
| 2019-12-31 | CN¥426.69 Million ≈ $62.44 Million |
+75.64% |
| 2018-12-31 | CN¥242.94 Million ≈ $35.55 Million |
+30.39% |
| 2017-12-31 | CN¥186.32 Million ≈ $27.26 Million |
+20.39% |
| 2016-12-31 | CN¥154.76 Million ≈ $22.65 Million |
-- |
About Beijing Succeeder Technology Inc
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and… Read more